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The strategies with which two viral genomes that consist of double-stranded nucleic acid
express themselves in infected cells are compared. The reovirus genome comprises ten segments
of double-stranded RNA, each of which is, in essence, a gene. Each is transcribed into plus-
stranded RNA which has two functions: to serve as messenger RNA for the synthesis ofthe ten
reovirus "primary" proteins, and to serve as template for the synthesis of minus-strands with
which they remain associated, thereby giving rise to progeny double-stranded RNA. One of
the most fascinating unsolved features of the reovirus multiplication cycle is the nature of
the mechanism that ensures that each progeny virus particle contains a complete set of the
ten individual genome RNA segments.
The vaccinia virus genome is a linear molecule of double-stranded DNA which possesses
sizable terminal redundancies (up to 7 percent, depending on the strain). The vaccinia virus
multiplication cycle can be divided into a well-defined early and late period. During the early
period, infecting virus particles are first uncoated to cores within which some 40-50 percent of
the viral genome is transcribed. These cores are then uncoated further to naked viral DNA, a
process that is mediated by protein(s) translated from the "core" messenger RNA. The overall
transcription pattern in highly complex and is regulated both at the transcriptional as well as at
the translational level. The most profound program changes occur at the time when DNA
replication begins, when the transcription of "early" messenger RNAs, some of which are
translated into "early" enzymes, gives way to that of "late" messenger RNAs, most of which
are translated into structural virus components.
The purpose of this briefreview is to compare the strategies with which the double-
stranded RNA containing reovirus and the double-stranded DNA containing
vaccinia virus express the information that they contain, and to highlight some recent
advances in our ability to detect and identify type-specific virus-coded proteins. Both
viruses belong to families that include some important human pathogens. The
Reoviridae include the rotaviruses which cause gastroenteritis, especially in infants,
which develops into a very severe disease when compounded by malnutrition and
lack of medical care; the Poxviridae include smallpox virus, probably mankind's
most devastating scourge through the ages, which, although on the point of being
eradicated, must yet be guarded against carefully for the foreseeable future.
REOVIRUS
The Reovirion
The genome of reoviruses, which are closely related to the rotaviruses, consists of
ten segments of double-stranded (ds) RNA (Fig. 1) encased within a capsid shell that
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FIG. 1. Autoradiogram of a 7.5 percent polyacrylamide gel in which the ten ds RNA segments of
reovirus type 3 (Dearing strain) had been electrophoresed. The direction of migration was from left to
right.
consists of two protein layers [1-3]. These ten segments contain the code for ten
proteins, eight of which are structural, that is, present within the virus particle, while
two are nonstructural. In addition, one of the structural proteins exists in the virus
particle in two forms: the form that is actually encoded in the viral genome, and a
cleavage product that is some 8,000 daltons smaller [4]. The nature, size, and amount
and location in virions of the reovirus-coded proteins are summarized in Table 1.
The ds RNA that is present in reovirus particles cannot express itselfin cells; there
are no enzymes in uninfected cells capable of transcribing ds RNA into ss RNA.
Instead the ds RNA is transcribed by a transcriptase that is present in latent form in
intact reovirus particles and is activated by removal of all or part of the outer capsid
shell [5-8]. All attempts to isolate this transcriptase have failed. Cores transcribe ds
into ss RNA very efficiently; but as soon as they are disrupted, enzyme activity
disappears. This has led to the notion that the enzyme is located on and is part ofthe
inner core surface, which would imply that the catalytic sites are fixed and that the
RNA templates move past them. The ss transcripts are released through 12 hollow
spikes that are distributed with icosahedral symmetry on the core surface [9]. The
mechanism of the transcription process is noteworthy; it is completely conservative
[7],just like the transcription ofds DNA into mRNA; that is, neither ofthe strands of
the template appears among the transcripts. Equally noteworthy are the kinetics of
transcription of each individual segment. Under optimal conditions in vitro the rate
of transcription of all segments is the same, regardless of their size, so that equal
amounts of all transcripts are formed, the frequency oftranscription ofeach segment
TABLE I
The Proteins Encoded by Reovirus
Approximate
Molecular Number of Molecules Location in
Species Weight Per Virion Virion
Al 155,000 100 Core
A2 140,000 100 Core spike
A3 140,000 12 Core(?)
,NS 88,000 Nonstructural
U 1 80,000 24 Outer shell (?)
P2 72,000 12 Outer shell (?)
PIIC 72,000 550 Outer shell
a1 42,000 12-24 Outer shell
o,2 38,000 200 Core
aNS 36,000 Nonstructural
a3 34,000 900 Outer shell
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being inversely proportional to its size. Since it is almost certain that the catalytic
enzyme sites are fixed and that the templates move past them, this implies that the ten
segments within each virus particle are unlinked. This is an important point relative
to reovirus morphogenesis where one of theprincipal, so far unanswered questions is
the nature of the mechanism that ensures that each progeny virus particle receives
one of each of ten different RNA segments. One possibility would, ofcourse, be that
the segments recognize each other in some manner. However, it is known that they
are notjoined end-to-end, that they do not hybridize with each other to a significant
extent (less than 1 percent), and that, asjust pointed out, they behave as independent
entities in their role as templates within virus particles.
The nature of the proteins encoded by each of the ten ds RNA segments has
recently been determined both by biochemical and by genetic means [10,11]. The
coding assignments are given in Table 2.
In addition to the ten segments of ds RNA, reovirions contain about 3,000
oligonucleotide molecules from 2-20 residues long, which fall into two classes. About
one-half consist only of A: these are the oligoadenylates. The remainder fall into the
following series: GCOH; GCUOH; GCUAoH; GCUA(U)1.4UoH; GCUA(A)1_3AoH
[12]. The function of these oligonucleotides is not known. One theory that has been
advanced for their presence is that they are formed during a terminal stage of
morphogenesis, immediately before the viriontranscriptase is inactivated (see below).
At this stage, it has been postulated, there is a brief period of time when only short
segments of template can be transcribed, and the products of this abortive transcrip-
tion are sealed into the maturing virions [12]. This conclusion is supported by the
fact that oligoadenylates are formed within the cores of nascent virions after the
completion of ds RNA synthesis [13], and the fact that no ts mutants of reovirus
synthesize oligoadenylates at nonpermissive temperatures (when the terminal stages
of viral maturation would not proceed) [14].
The Reovirus Multiplication Cycle
The overall strategy ofthe reovirus multiplication cycle is shown in Fig. 2. It can be
divided into an early and a late period, the demarcation between them being the onset
of progeny ds RNA formation. During the early period, the following functions are
performed.
Uncoating. Reovirus is taken up into cells within phagocytic vacuoles which fuse
TABLE 2
Nature of the Protein Encoded by Each of the Ten Segments of Reovirus ds RNA
Segment Protein
LI A3
L2 A2
L3 Al
Ml y2
M2 jL1
M3 pNS
Si al
S2 a2
S3 aNS
S4 a3
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FIG. 2. The strategy of the reovirus gene expression program. For details see text.
with lysosomes within which their outer capsid shell is partially degraded by the
removal of polypeptides ar3 and alI and an 8,000 to 12,000 dalton fragment ofAulC
[15,16]. The resulting particles, termed subviral particles (SVPs), are then liberated
into the cytoplasm where they transcribe parental genome RNA into mRNA, but
otherwise persist unchanged until the late stages of the infection cycle, when
polypeptides cr1 and ar3 reassociate with them, and they are then liberated together
with progeny virions. At no stage during the multiplication cycle does parental ds
RNA exist free within the infected cell.
The Intracellular Transcription of Reovirus RNA. The SVPs transcribe parental
ds RNA into mRNA molecules which are exactly as long as their templates; and they
are capped and methylated at their 5' ends [17]. However, in distinction to most other
types of mRNAs, they are not polyadenylated at their 3' ends. The frequency with
which the ten ds RNA templates are transcribed is not identical with that occurring in
vitro under optimal conditions, when the frequency of transcription is inversely
proportional to the size of each segment (see above); instead, there are major
deviations, especially for the larger segments which are transcribed less frequently
than expected. The most probable reason for this is that the intracellular Mg++ and
XTP concentrations are not those necessary for optimal rates of transcription.
Messenger RNA molecules synthesized during the early period of the reovirus
multiplication cycle contain exclusively cap 1 (m7GpppGmpCp ... ); later about one-
third of the mRNA molecules possess cap 2, which contains an additional methyl
group (m7GpppGmpCmp ... ) [18]. Transcripts containing cap 1 are also synthesized
in vitro by reovirus cores and are therefore formed exclusively by enzymes present in
reorivions. Whether all capping and methylating enzymes are virus-coded, or
whether some are present in cores but are host-specified, is not known.
Translation of Reovirus mRNA. The ten species of mRNA that are synthesized
during the early period are translated into polypeptides. The relative frequencies with
which the various mRNA species are translated within infected cells are very similar
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to those with which they are translated in vitro. Therefore no specific control
mechanisms regulating the frequency oftranslation ofreovirus mRNA species appear
to exist; such mechanisms as there are must reside within the mRNA molecules
themselves. Since it is possible to measure precisely the frequencies with which the
individual species of mRNA and polypeptides are synthesized, it is possible to
determine the relative efficiencies with which each species of mRNA is translated. It
turns out that some species are translated more than 30 times as frequently as others
(Table 3).
Impressive progress has been made recently sequencing the reovirus mRNAs; the
5'-terminal 30-40 residues of 3 s species and of 3 m species of RNA have been
reported [19-21]. The first AUG which could function as an initiation codon is
located from 15 to 33 residues from the 5'-terminus, depending on the RNA species.
The Late Period. After several hours, and presumably when a certain amount ofss
RNA molecules and viral proteins has accumulated, morphogenesis commences. The
first stage consists of the formation of structures that contain several reovirus-coded
proteins among which the nonstructural protein , NS is prominent, and sets of the
ten species of ss RNA. Within these particles, which are sensitive to ribonuclease,
each of the ten species of mRNA is transcribed once and once only into a minus
strand which remains associated with it, thereby giving rise to the progeny ds RNA
molecules [22-24]. The enzyme that catalyzes this transcription has not yet been
isolated, but is in all probability a form of the transcriptase that transcribes ds RNA
molecules into ss RNA molecules during the early phase of the infection cycle.
Nothing is known concerning the nature of the interactions that ensure that each
progeny virus particle contains a complete and unique set of all ten reovirus RNA
molecules; it seems likely that both protein-RNA and RNA-RNA interactions are
involved, since neither alone seems sufficiently strong. The protein composition of
these immature virus particles then gradually changes until particles result that
resemble cores, and finally mature virions appear [25]. Throughout this morphoge-
netic pathway the immature virus particles transcribe the ds RNA that they contain
into mRNA molecules, just like parental SVPs during the early period. In fact, since
TABLE 3
Approximate Relative Frequencies of Transcription and Translation of the Ten Species of Reovirus
mRNA in vivo (3)
Translation
frequency
mRNA Transcription Polypeptide Translation Transcription
Species frequency species frequency frequency
11 0.05 A3 <0.02 <0.4
12 0.05 A2 0.15 3
13 0.05 Al 0.1 2
ml 0.15 2 0.015 0.1
m2 0.3 MI + MiC 1.0 3.3
m3 0.5 ;NS 0.5 1
sl 0.5 al <0.05 <0.1
s2 0.5 a2 0.2 0.4
s3 1.0 aNS 0.3 0.3
s4 1.0 a3 0.7 0.7
31there are many more immature virus particles in cells than parental particles, most
(about 95 percent) of the mRNA that is formed during the infection cycle is
transcribed from immature virus particles [26]. The transcriptase is active in
immature virus particles until the outer capsid shell is completed during the final
stage of morphogenesis, and it is presumably at that stage that the shut-off of
transcriptase activity leads to the trapping within the nascent mature virus particles
of the oligonucleotides, the abortive products of transcription during the final
moments before it is shut off.
The Nature ofthe Type-Specific Reovirus RNA Sequences
Three reovirus serotypes are known, each consisting of several closely related
strains. It is of great interest to determine where the RNA sequences are that differ in
the genomes of strains belonging to these three serotypes, and which are the type-
specific proteins.
This problem can be approached in two ways: analysis ofthe ability ofthe RNA of
strains of the three serotypes to hybridize with each other, and analysis of the
serological relatedness of the proteins coded by strains of the three serotypes.
It can be shown by several techniques, such as ds RNA-ds RNA or ds RNA-ss
RNA hybridization, that strains of serotypes 1 and 3 are related to the extent of
about 80 percent, whereas strains of serotype 2 are related to those of the other two
serotypes only to the extent of about 10 percent [27,28], the criterion in each case
being the resistance of hybrids to RNase under conditions when homologous
hybridization is arbitrarily assigned a value of 100 percent. A more refined type of
analysis is to observe the electrophoretic migration behavior of individual hybrid
RNA segments. It is known that the greater the mismatch between the two strands of
hybrid ds RNA molecules, the more slowly do they migrate in polyacrylamide gels
relative to homologous hybrids in which both strands are derived from the same virus
strains and which, by definition, exhibit perfect base pairing(100 percent homology).
When this type ofanalysis is carried out with the RNAs of strains ofserotypes 1 or 3
on the one hand and serotype 2 on the other, it is found that there is tremendous
mismatching in all segments; in fact, only segments S3 and S4 will enter the 7.5
percent polyacrylamide gels in which electrophoresis is normally carried out, all
others being so mismatched that they fail to enter. When a similar analysis is carried
out with the RNAs of serotypes 1 and 3, the various segments are retarded to varying
degrees, indicating different degrees of mismatching (Fig. 3); and we are engaged at
this time in correlating the extent of mismatching as quantitated by digestion with ss
RNA-specific nucleases with the extent of retardation. One segment, however, will
not enter gels at all, indicating serious mismatching: this is segment S1 which codes
for polypeptide or 1. This segment clearly contains the most type-specific information
of reoviruses.
This assessment fits in well with data that demonstrate that polypeptide al is the
primary type-specific determinant of reovirus, and that it is also the reovirus
hemagglutinin and controls host-specificity and the nature ofthe pathogenic changes
that reovirus causes [29-32]. We have recently taken this analysis further and started
to quantitate the immunologic relatedness of all ten proteins coded by reovirus. The
approach is as follows. We have prepared antisera to strains ofthe three serotypes in
pathogen-free rabbits. These antisera were then used to precipitate reovirus-coded
polypeptides from extracts of radioactively labelled infected cells. The immune
precipitates were collected on staphylococcal A protein and the amount of each
precipitated polypeptide was quantitated after polyacrylamide gel electrophoresis
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FIG. 3. Autoradiogram of a 7.5 percent polyacrylamide slab I,,r
gel in which hybrid ds RNA segments of reovirus RNA had been
electrophoresed. These hybrids were prepared by hybridizing
radioactively labeled plus-stranded RNA with an excess of unla-
beled ds RNA; in all cases shown here the ds RNA was that of
S 2 g | reovirus type 3, and the plus-stranded RNA was that of reovirus
type 3 (homologous hybrids) (slot 1), reovirus type 1 (slot 2) and
reovirus type 2 (slot 3) (heterologous hybrids). Note that the
heterologous hybrids of reovirus type 3/reovirus type I RNA are
retarded relative to the homologous reovirus type3/reovirus type 3
RNA hybrids, and that most of the heterologous reovirus type
3/reovirus type 2 RNA hybrids are retarded so severely that they
are unable to enter thegel; the two hybrids that are visible are those
" of segments S4 and S3 [28].
and autoradiography. By using various concentrations of antisera, and by using the
antisera and the extracts of infected cells in both homologous and heterologous
combinations, it has been possible to quantitate the immunologic relatedness of the
reovirus polypeptides. This analysis also indicated that by far the most private or
type-specific of the reovirus-coded polypeptides is polypeptide al; forexample, there
is no immunologic relatedness whatsoever between the al polypeptides of reovirus
types 1 and 3, and there is only a smalJ degree of relatedness between the O' 1 of
serotype 2 on the one hand and that of serotypes 1 and 3 on the other. As for the
other reovirus-coded polypeptides, all of them show a very high degree of serologic
relatedness, even those of serotype 2 on the one hand and serotypes 1 and 3 on the
other. This is a most surprising result, since, as pointed out above, hybridization
analysis of the RNAs of strains of serotype 2 on the one hand and serotypes 1 and 3
on the other showed very marked mismatching. It seems therefore that for all
polypeptides except d, the sequences that contain the immunologic determinants of
reovirus polypeptides have been greatly conserved during evolution, while the other
sequences have diverged widely; for polypeptide cr1, both types of sequences have
diverged extensively.
VACCINIA VIRUS
The Vaccinia Virus Particle
The genome of vaccinia virus consists of a single ds DNA molecule with a
molecular weight of about 125 million. The two strands are linked covalently very
close to or, most likely, at their ends; on melting, vaccinia DNA gives rise to a circle,
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bonds holding the two strands together are susceptible to hydrolysis by ss DNA-
specific nucleases. The arrangement of genetic information in vaccinia DNA has
recently begun to be explored with the preparation of restriction endonuclease maps
[33]. Mapping has revealed that vaccinia DNA contains large inverted terminal
repeats that differ in size from strain to strain and may be as large as 8 million daltons
[34,35]. These terminal regions are subject to marked genetic instability; in stocks of
uncloned virus strains the lengths of the terminal repeats are heterogeneous, and it is
only upon cloning that populations of virus particles with identically sized repeats are
obtained. Clearly, deletions are readily induced in these terminally repeated regions,
and it has been found that the deletions at each end are always identical. This bizarre
behavior raises the question as to the source of the genetic information necessary to
create longer repeats, as happens when clones with short repeats are passaged
repeatedly to generate virus populations in which they are again heterogeneous.
The vaccinia virus particle itself is a highly complex structure that comprises at
least 50 species of polypeptides each present to the extent of more than 100 copies
each; the total number ofvirus-coded species may well exceed 100. The vaccinia virus
genome is large enough to encode this number of proteins; a ds DNA of 125 million
daltons is large enough to code for 200 protein species with an average molecular
weight of 35,000, even if each coding sequence is used only once. It should be noted
that recent work with other systems, such as 4X174 [36] and polyomaviruses[37],
has indicated that coding sequences may well be used several times to code for
different proteins.
The gross morphological features of vaccinia virus particles include a centrally
located core that contains the DNA and a surrounding "outer protein coat" that is
contained within a surface layer, a prominent feature of which are rodlets or tubules
that are arranged in a characteristic whorled arrangement (and that display a highly
regular and uniform pattern in parapoxvirus particles). The vaccinia virus core
contains an arsenal of enzymes, many of which have been isolated and characterized.
First there is an RNA polymerase which is absolutely essential since infecting ds
DNA lodges in thecytoplasm of infected cells, where there are no enzymes capable of
transcribing ds DNA into mRNA. There are also capping enzymes, a poly A
polymerase (in distinction to reovirus mRNAs, vaccinia virus mRNAs are polyadeny-
lated at their3'-termini), a cyclic AMP-independent protein kinase, a DNA nicking-
closing enzyme that relaxes both left- and right-handed superhelical DNA, two ss
DNA-specific nucleases, and two DNA-dependent nucleoside triphosphatases. Many
of these enzymes may be involved in the replication and packaging of DNA, and in
the transcription and extrusion of nascent mRNA from cores. Vaccinia virus is also
being examined for "splicing" enzymes. It has been reported that some of the RNA
transcripts synthesized in vitro by vaccinia virus cores are very large and are
"processed" as they are extruded [38]. There is, however, clear evidence from UV-
transcriptional mapping studies that transcripts of vaccinia DNA are monocistronic
[39].
The Vaccinia Virus Multiplication Cycle
Vaccinia virus particles enter cells via phagocytic vacuoles within which they are
broken down to cores which are liberated into the cytoplasm. Stripping away of the
outer regions of vaccinia virus particles results in the activation of the DNA-
dependent RNA polymerase which is latent in intact virus particles. Transcription of
the viralgenome commences within cores, almost 50 percent of the viral DNA being
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transcribed. Expression of some early viral gene product appears to be necessary for
the uncoating of cores, since naked viral DNA is not liberated if it is prevented or
impossible (as, for example, if cells are infected with heat- or urea-inactivated virus
particles). It seems that an "uncoating protein" is synthesized that is capable of
effecting the uncoating not only of the cores that code for it (homologous cores), but
also heterologous ones. For example, if cells infected with vaccinia virus are
superinfected some time (for example, three hours) later with particles of another
poxvirus strain, they are immediately uncoated by the mediation of the uncoating
protein specified by the first-infecting virus.
Once the viral DNA has been uncoated, it continues to be transcribed, apparently
to roughly the same extent as DNA in cores. Relatively few of the proteins that are
translated from this early messenger RNA are known. Some are enzymes such as a
DNA polymerase, a thymidine kinase, a polynucleotide 5'-triphosphatase, and the
capping enzymes. Some of the others, but only a very few, are capsid proteins, and
some are proteins that become associated with the DNA just before and while it
replicates. Vaccinia virus DNA replicates within a relatively brief interval of time,
from about 2 to 4 hours after infection; vaccinia virus is atypical in this respect, since
the DNAs of most other DNA-containing viruses replicate during the entire late
period of the infection cycle.
Progeny DNA molecules are transcribed more extensively than parental ones: not
only are some of the early sequences still transcribed from them, but also all the late
ones. In fact, the vaccinia transcription pattern is extremely complex: it constantly
changes, as is readily shown by pulse-labeling cells at hourly intervals and examining
autoradiograms of polyacrylamide gels in which extracts of infected cells had been
electrophoresed. This relatively simple technique is highly effective because vaccinia
virus, like numerous other lytic viruses including reovirus, inhibits host protein
synthesis very efficiently, so that even as early as one hour after infection most of the
proteins formed in infected cells are virus-specified. When such gel autoradiograms
are examined during the first 20 hours of the infection cycle (Fig. 4), it is clearly
apparent that the pattern of viral gene expression constantly changes. Not only are
there early proteins that are synthesized only during the early period, early proteins
that continue to be synthesized in the late period, late proteins that are only
synthesized in the early part of the late period and late proteins that are synthesized
throughout the late period, but each of these four protein classes can be subdivided
further; it may well be that most vaccinia proteins are under their own transcriptional
and perhaps also translational controls [40,41]. In fact, the vaccinia virus multiplica-
tion cycle exhibits one of the relatively few well-known examples of translational
control: it is known that the reason why the synthesis of early proteins such as the
DNA polymerase or the thymidine kinase is arrested at the beginning of the late
period is not the fact that their messenger RNAs are no longer synthesized and that
their messenger RNAs are short-lived, but rather that their translation is actively
prevented by a protein that is formed at the beginning of the late period. This
phenomenon is known as the "switch-offs" phenomenon [42]. It is demonstrated most
readily by comparing the kinetics of early enzyme synthesis in cells infected with
infectious vaccinia virus, with UV-inactivated vaccinia virus, and with both: in the
first case early enzyme synthesis is switched off; in the second it is not; in the third it is
[42]. Synthesis of early enzymes is therefore controlled not at the transcriptional, but
at the translational level. Most of the remainder of the vaccinia virus gene expression
program, however, is controlled at the transcriptional level.
Vaccinia virus morphogenesis proceeds as soon as progeny DNA molecules have
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of vaccinia virus specified poly-
peptide formation during the
multiplication cycle. At the times
indicated cells infected with vac-
40 cinia virus were labeled with 35S-
methionine for one hour. The
cells were then harvested, cyto-
plasmic cell extracts were pre-
pared, and the polypeptides in
them were separated by electro-
phoresis in SDS-polyacrylamide
25 gels, which were then autora-
diographed. U, uninfected cells;
0.5, etc., shows the polypeptide
species synthesized during the
time intervals from 0.5 to 1.5 h,
etc., after infection. Note that the
pattern of polypeptide synthesis
changes throughout the multipli-
cation cycle [38].
formed. Progeny DNA molecules are withdrawn at random from the pool of
replicated DNA that accumulates between 2 and 4 h after infection and are then
encapsidated via a series of reactions that, for each individual DNA molecule, take
about one hour [43]. Obviously there must be numerous intermediates during the
maturation of particles as complex as vaccinia virus particles, but few have been
characterized. One that has been observed is a spherical particle that is composed of
only two major polypeptide species, one being the core surface component, the other
a phosphorylated polypeptide that is present in virions in very small amounts only
[44-46].
Comparison ofthe Multiplication Cycles of Reovirus and Vaccinia Virus
It is seen that although the genomes of both reovirus and vaccinia virus consist of
double-stranded nucleic acid, their gene expression strategies are quite different. In
fact, the gene expression strategy ofreovirus resembles much more closely that ofthe
ss RNA containing viruses: reovirus can really be regarded as a virus whose genome
is single-stranded RNA (which clearly provides the genetic continuity between
parental and progeny virus particles), but which has the idiosyncrasy that the RNA
form that is encapsidated is not ss (plus-stranded or minus-stranded) RNA, but its
replicative form.
The Identification of Type-Specific Poxvirus Proteins
Smallpox virus appears to have been eliminated as a human pathogen; no
naturally occurring cases of smallpox, either variola major or variola minor, have
been reported during the last year, and WHO plans to pronounce smallpox
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eradicated at the end of this year. This brings up the question of whether smallpox
vaccination, which is still being carried out in Africa and Asia, should continue or
whether it should cease. The decision is predicated largely on the potential effect
upon man of several closely related viruses that occur or may occur in nature. These
are of two types. The first is monkeypox virus, which causes a severe disease not only
in monkeys but also in man, with a case mortality of up to 30 percent, but which is
not transmissable, or only very poorly transmissable, from man to man; no epidemic
of monkeypox virus in man has ever been observed, and even contacts ofmonkeypox
virus cases do not contract the disease. The second are the so-called whitepox viruses
which have been isolated both from monkey and from rodent tissues in various parts
of the world, and which, according to all available evidence, are indistinguishable
from smallpox virus. These whitepox viruses are either smallpox virus variants with
an altered host range (since classical smallpox virus has only one host, man), in which
case they pose a severe threat to man; orthey are laboratory contaminants (since they
were isolated in laboratories that were also handling smallpox virus at the time).
However that may be, it is clearly very important to devise reagents that can
rapidly identify and differentiate between smallpox virus, whitepox viruses, and
monkeypox virus. The best reagents for this purpose would be antibodies to type-
specific poxvirus determinants. We are endeavoring to obtain such reagents in the
following manner. First, we are devising techniques for identifying type-specific
poxvirus determinants. This is being done by immunoprecipitating extracts of cells
infected with various strains of poxvirus with antisera to both homologous and
heterologous poxviruses, collecting the precipitates on staphylococcal A protein, and
examining the virus-specific polypeptides in them by polyacrylamide gel electropho-
resis followed by autoradiography. We have already shown that when homologous
and heterologous immunoprecipitates ofthis type are compared, most viral polypep-
tides are precipitated by both homologous and heterologous antisera, but that some
are only precipitated by homologous antisera. This is the case even when pairs ofvery
closely related viruses are examined. The polypeptides that are only precipitated by
homologous and not by heterologous antisera are clearly the type-specific ones.
As the next step we are attempting to isolate hybridomas to vaccinia virus-coded
proteins, using for this purpose techniques that we have developed while preparing
hybridomas to reovirus-coded polypeptides (we presently have hybridomas that
produce monoclonal antibodies to seven of the ten reovirus proteins). Hybridomas
that produce antibodies to type-specific poxvirus proteins will obviously be ex-
tremely useful for identifying any particular virus rapidly and definitively. Further-
more, knowledge of which poxvirus proteins are type-specific is also useful for
screening animal sera for the presence of the corresponding antibodies, thereby
providing evidence of previous exposure and infection.
In summary, I have compared the strategy ofthe multiplication cycles ofreoviruses
and poxviruses and described examples of how this information may be applied to
problems relevant to diagnostic virology. There is every indication that the more is
known about the molecular events that occur during virus multiplication, the more
rapidly and definitively will one be able to detect and identify viral pathogens.
REFERENCES
1. Shatkin AJ, Sipe JD, Loh PC: Separation of ten reovirus genome segments by polyacrylamide gel
electrophoresis. J Virol 2:986-998, 1968
2. Smith RE, Zweerink HJ, Joklik WK: Polypeptide components ofvirions, top component and cores of
reovirus type 3. Virology 39:791-810, 196938 W.K. JOKLIK
3. Joklik WK: Reproduction of reoviridae. Comprehensive Virology, Vol 2. Edited by H Fraenkel-
Conrat and RR Wagner. New York and London, Plenum Press, 1974, pp 231-334.
4. Zweerink HJ, Joklik WK: Studies on the intracellular synthesis of reovirus-specified proteins.
Virology 41:501-518, 1970
5. Shatkin AJ, Sipe JD: RNA polymerase activity in purified reoviruses. Proc Natl Acad Sci USA
61:1462-1469, 1968
6. Borsa J, Graham AF: Reovirus: RNA polymerase activity in purified virions. Biochem Biophys Res
Commun 33:896-901, 1968
7. Skehel JJ, Joklik WK: Studies on the in vitro transcription of reovirus RNA catalyzed by reovirus
cores. Virology 39:822-831, 1969
8. Joklik WK: Studies on the effects of chymotrypsin on reovirions. Virology 49:700--715, 1972
9. Luftig RB, Kilham SS, Hay AJ, et al: An ultrastructural study of virions and cores ofreovirus type 3.
Virology 48:170-181, 1972
10. McCrae MA, Joklik WK: The nature of the polypeptide encoded by each of the ten double-stranded
RNA segments of reovirus type 3. Virology 89:578-593, 1978
11. Mustoe TA, Ramig RF, Sharpe AH, et al: Genetics ofreovirus: Identification ofthe ds RNA segments
encoding the polypeptides of the A and a size classes. Virology 89:594-604, 1978
12. Nichols JL, Bellamy AR, Joklik WK: Identification of the nucleotide sequences of the oligonucleo-
tides present in reovirions. Virology 49:562-572, 1972
13. Silverstein SC, Astell C, Christman J, et al: Synthesis of reovirus oligo adenylic acid in vitro and in
vivo. J Virol 13:740-752, 1974
14. Johnson RB Jr, Soeiro R, Fields BN: The synthesis of A-rich RNA by temperature-sensitive mutants
of reovirus. Virology 73:173-180, 1976
15. Chang C, Zweerink HJ: Fate of parental reovirus in infected cell. Virology 46:544-555, 1971
16. Silverstein SC, Astell C, Levin DH, et al: The mechanisms of reovirus uncoating and gene activation
in vivo. Virology 47:797-806, 1972
17. Shatkin AJ: Methylated messenger RNA synthesis in vitro by purified reovirus. Proc Natl Acad Sci
USA 71:3204-3207, 1974
18. Desrosiers RC, Sen GC, Lengyel P: Difference in 5' terminal structure between the mRNA and the
double-stranded virion RNA of reovirus. Biochem Biophys Res Commun 73:32-39, 1976
19. Nichols JL, Hay AJ, Joklik WK: 5' terminal nucleotide sequence of reovirus mRNA synthesized in
vitro. Nature New Biology 235:105-107, 1972
20. Kozak M, Shatkin AJ: Identification offeatures in 5' terminal fragments from reovirus mRNA which
are important for ribosome binding. Cell 13:201-212, 1978
21. Lazarowitz SG, Robertson HD: Initiator regions from the small size class ofreovirus messenger RNA
protected by rabbit reticulocyte ribosomes. J Biol Chem 252:7842-7849, 1977
22. Acs G, Klett H, Schomberg M, et al: Mechanism of reovirus double-stranded ribonucleic acid
synthesis in vivo and in vitro. J Virol 8:684-689, 1971
23. Sakuma S, Watanabe Y: Incorporation of in vitro synthesized reovirus double-stranded ribonucleic
acid into reovirus corelike particles. J Virol 10:943-950, 1972
24. Morgan EM, Zweerink HJ: Characterization of transcriptase and replicase particles isolated from
reovirus-infected cells. Virology 68:455-466, 1975
25. Morgan EM, Zweerink HJ: Reovirus morphogenesis: corelike particles in cells infected at 390 with
wild-type reovirus and temperature-sensitive mutants of groups B and G. Virology 59:556-565, 1974
26. Lai MT, Joklik WK: The induction of interferon by temperature-sensitive mutants of reovirus, UV-
irradiated reovirus, and subviral reovirus particles. Virology 51:191-204, 1973
27. Martinson HG, Lewandowski LJ: Sequence homology studies between the double-stranded RNA
genomes of cytoplasmic polyhedrosis virus, wound tumor virus and reovirus strains 1, 2 and 3.
Intervirology 4: 91-98, 1974
28. Gaillard RK, Joklik WK: Unpublished results
29. Weiner HL, Fields BN: Neutralization of reovirus: the gene responsible for the neutralization antigen.
J Exp Med 146:1305-1310, 1977
30. Weiner HL, Ramig RF, Mustoe TA, et al: Identification of the gene coding for the hemagglutinin of
reovirus. Virology 86:581-584, 1978
31. Weiner HL, Drayna D, Averill DR Jr, et al: Molecular basis of reovirus virulence: the role of the S1
gene. Proc Nat Acad Sci USA 74:5744-5748, 1977
32. Finberg R, Weiner HL, Fields BN, et al: Generation of cytolytic T lymphocytes after reovirus
infection: Role of S1 gene. Proc Natl Acad Sci USA 76:442-446, 1979
33. Wittek R, Menna A, Schumperli D, et al: Hind IIl and Sst I restriction sites mapped on rabbitpox
virus and vaccinia virus DNA. J Virol 23:669-687, 1977REOVIRUS AND VACCINIA VIRUS 39
34. Wittek R, Menna A, Mueller HK, et al: Inverted terminal repeats in rabbitpox virus and vaccinia virus
DNA. J Virol 28:171-181, 1978
35. Garon CF, Barbosa E, Moss B: Visualization ofan inverted terminal repetition in vaccinia virus DNA.
Proc Natl Acad Sci USA 75:4863-4867, 1978
36. Sanger F, Air GM, Barrell BG, et al: Nucleotide sequence of bacteriophage -OX 174 DNA. Nature
265:687-695, 1977
37. Smart JE, Ito Y: Three species ofpolyoma virus tumorantigens share common peptides probably near
the amino termini of the proteins. Cell 15:1427-1437, 1978
38. Paoletti E: In vitro synthesis of a high molecular weight virion-associated RNA by vaccinia. J Biol
Chem 252:866-871, 1977
39. Pelham HRB: Use of coupled transcription and translation to study mRNA production by vaccinia
cores. Nature 269:532-534, 1977
40. Cooper JA, Moss B: Transcription of vaccinia virus mRNA coupled to translation in vitro. Virology
88:149-165, 1978
41. Pennington TH: Vaccinia virus polypeptide synthesis: sequential appearance and stability of pre- and
post-replicative polypeptides. J Gen Virol 25:433-444, 1974
42. McAuslan BR: Control of induced thymidine kinase activity in the poxvirus-infected cell. Virology
20:162-168, 1963
43. Joklik WK, Becker Y: The replication and coating of vaccinia DNA. J Mol Biol 10:452-474, 1964
44. Sarov 1, Joklik WK: Isolation and characterization of intermediates in vaccinia virus morphogenesis.
Virology 52:223-233, 1973
45. Morgan C: Vaccinia virus reexamined: development and release. Virology 73:43-58, 1976
46. Nagayama A, Pogo BGT, Dales S: Biogenesis of vaccinia: separation of early stages from maturation
by means of rifampicin. Virology 40:1039-1051, 1970